why choose us

First received: October 26, 2022

Clinical Trial: Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Granulomatous Disease

Study Type: INTERVENTIONAL


Official Title: Pilot Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)

Brief Summary: Background:Chronic granulomatous disease (CGD) is a rare immune disorder that can cause serious infections throughout the body.The only cure for CGD is a stem cell transplant.Transplants from a sibling are best, but many people must get transplants from unrelated donors.However, these transplants can cause serious complications in people with CGD.Objective:To see if a study drug (JSP191) can help improve the success rates of stem cell transplants for people with CGD from an unrelated donor.Eligibility:People aged…

Read more